OWLT:NYE-Owlet Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 4.28

Change

-0.19 (-4.25)%

Market Cap

USD 0.04B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
VEEV Veeva Systems Inc Class A

+1.82 (+0.91%)

USD 32.00B
SOLV Solventum Corp.

+2.60 (+4.21%)

USD 11.73B
DOCS Doximity Inc

+0.23 (+0.97%)

USD 4.83B
EVH Evolent Health Inc

-0.67 (-2.37%)

USD 3.36B
TDOC Teladoc Inc

-0.32 (-2.40%)

USD 2.20B
AGTI Agiliti Inc

+0.01 (+0.10%)

USD 1.37B
PHR Phreesia Inc

+0.15 (+0.73%)

USD 1.30B
SLP Simulations Plus Inc

-0.96 (-2.10%)

USD 0.88B
MPLN MultiPlan Corporation

N/A

USD 0.43B
AMWL American Well Corp

-0.01 (-2.13%)

USD 0.16B

ETFs Containing OWLT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.94% 36% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.94% 36% F 5% F
Trailing 12 Months  
Capital Gain -6.34% 82% B 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.34% 82% B 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -40.13% 9% A- 1% F
Dividend Return -40.13% 9% A- 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 53.06% 55% F 17% F
Risk Adjusted Return -75.64% 27% F 4% F
Market Capitalization 0.04B 18% F 17% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector